Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology and cancer incidence.

MLA

Lee, Andrew, et al. “Enhancing the BOADICEA Cancer Risk Prediction Model to Incorporate New Data on RAD51C, RAD51D, BARD1 Updates to Tumour Pathology and Cancer Incidence.” Journal of Medical Genetics, vol. 59, no. 12, Dec. 2022, pp. 1206–18. EBSCOhost, https://doi.org/10.1136/jmedgenet-2022-108471.

APA

Lee, A., Mavaddat, N., Cunningham, A., Carver, T., Ficorella, L., Archer, S., Walter, F. M., Tischkowitz, M., Roberts, J., Usher-Smith, J., Simard, J., Schmidt, M. K., Devilee, P., Zadnik, V., Jürgens, H., Mouret-Fourme, E., De Pauw, A., Rookus, M., Mooij, T. M., & Pharoah, P. P. D. (2022). Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology and cancer incidence. Journal of Medical Genetics, 59(12), 1206–1218. https://doi.org/10.1136/jmedgenet-2022-108471

Chicago

Lee, Andrew, Nasim Mavaddat, Alex Cunningham, Tim Carver, Lorenzo Ficorella, Stephanie Archer, Fiona M. Walter, et al. 2022. “Enhancing the BOADICEA Cancer Risk Prediction Model to Incorporate New Data on RAD51C, RAD51D, BARD1 Updates to Tumour Pathology and Cancer Incidence.” Journal of Medical Genetics 59 (12): 1206–18. doi:10.1136/jmedgenet-2022-108471.